Insys Therapeutics

About:

Insys Therapeutics is a specialty pharmaceutical company that develops and commercializes innovative supportive care products.

Website: http://www.insysrx.com

Description:

Insys Therapeutics is a commercial-stage specialty pharmaceutical company that develops and commercializes innovative supportive care products. We have two marketed products, Subsys and Dronabinol SG Capsule, which leverage our sublingual spray drug delivery technology and dronabinol formulation and manufacturing capabilities, respectively. In March 2012, we launched Subsys, our proprietary sublingual fentanyl spray for breakthrough cancer pain, or BTCP, in opioid-tolerant patients.

Total Funding Amount:

$2.32M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Chandler, Arizona, United States

Founded Date:

1990-06-01

Founders:

John Kapoor

Number of Employees:

501-1000

Last Funding Date:

2011-03-28

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai